Opioid Withdrawal Management Market

Future Market Insights

Key Insight

The opioid withdrawal management market is projected to grow from USD 3.1 billion in 2025 to USD 5.3 billion by 2035, at a CAGR of 5.3%. Opioid Agonists will dominate with a 42.6% market share, while hospitals will lead the end users segment with a 55.8% share.

September 15, 2025

Anurag Sharma

275 Pages

Cite this Report

Opioid Withdrawal Management Market

https://www.futuremarketinsights.com/reports/opioid-withdrawal-management-market

License

Buy Now

Summary ToC Companies

Key Players

Actavis Elizabeth
Alkermes plc
BioDelivery Sciences
Dr. Reddy’s Laboratories
Financiere Verdi
Hikma Pharmaceuticals PLC
Indivior PLC
Mallinckrodt Pharmaceuticals
Mylan
Orexo AB
Rhodes Pharmaceuticals
Sun Pharmaceutical Industries Ltd
Teva

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Opioid Withdrawal Management Market

Key Players

Similar Industry Reports